Dociparstat in Combination With Standard Chemotherapy for the Treatment of Acute Myeloid Leukemia
Study sponsor: Jazz Pharmaceuticals
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-05-16Actual
Enrollment · participants9Actual
Source updated2024-04-15Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.